Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification.

Huiqiong BaoXiaobin LiZhixing CaoZhihong HuangLi ChenMingbing WangJiali HuWenting LiHongwei SunXue JiangPing MeiHuawen LiLi-Gong LuMeixiao Zhan

Published in: Journal of translational medicine (2022)

This study is the first to demonstrate that COPA may contribute to progression of cervical cancer. It can serve as a potential prognostic biomarker and promising intervention target for cervical cancer.

Keyphrases

randomized controlled trial
mass spectrometry
high resolution
risk assessment
label free